⚠️ Disclaimer As of my last update (June 2024), Wainua is not an approved or widely documented pharmaceutical product. Consequently, no peer‑reviewed pharmacologic data are publicly available. The following outline is provided purely as a template. When real data become available—or if you are working with a similar, licensed compound—replace the placeholders with verified information. — … Read more
Vyvanse Vyvanse (lisdexamfetamine dimesylate) is a central nervous system stimulant approved for attention‑deficit/hyperactivity disorder (ADHD) and binge‑eating disorder (BED). It is a dextro‑amphetamine prodrug that offers a predictable, extended‑release profile with lower abuse potential compared with immediate‑release amphetamines. Mechanism of Action Prodrug activation: Oral Vyvanse is hydrolyzed by red‑blood‑cell and plasma enzymes to release free … Read more
Vyndamax Mechanism of Action Dasatinib (Vyndamax) is a second‑generation tyrosine kinase inhibitor that targets the BCR‑ABL1 fusion protein and Src family kinases. It binds directly to the ATP‑binding pocket of BCR‑ABL1, preventing autophosphorylation and downstream signaling through substrates such as STAT5, STAT6, and CRK. By inhibiting these pathways, Vyndamax induces apoptosis in Philadelphia‑chromosome positive leukemic … Read more
Vyepti > Note: As of the current knowledge cut‑off (January 2026), Vyepti is not a commercially available or FDA‑approved drug. Published literature contains no peer‑reviewed pharmacology or clinical‑use data for a product by this name. The following card is a template that follows the requested structure and can be populated once credible information becomes available. For … Read more
Vraylar Vraylar (cariprazine) is a second‑generation antipsychotic indicated for the treatment of schizophrenia and bipolar I disorder (manic episodes). It is distinguished by its high affinity for dopamine D3 receptors and a unique partial‑agonist profile that offers potential advantages in negative symptoms and metabolic tolerability. Mechanism of Action Partial agonist at dopamine D2 and D3 … Read more
Voydeya Voydeya (dapivirine vaginal gel 0.5 % w/w) – a topical antiretroviral for HIV‑1 pre‑exposure prophylaxis (PrEP) in women. Mechanism of Action Non‑nucleoside reverse transcriptase inhibitor (NNRTI) Binds to the allosteric pocket of HIV‑1 reverse transcriptase. Induces a conformational change that blocks the enzyme’s catalytic activity, preventing viral DNA synthesis and replication. Topical delivery concentrates drug … Read more
Votrient Votrient (MK‑8776) is an oral, small‑molecule, selective inhibitor of protein kinase B (AKT). It is studied primarily for hematologic malignancies and solid tumors with aberrant AKT signaling. Mechanism of Action Selective ATP‑competitive inhibitor of AKT1, AKT2, and AKT3 isoforms. Blocks phosphorylation of downstream substrates such as mTOR, FOXO, and BAD, interrupting cell‑survival, proliferation, and … Read more
Vosevi Vosevi is the first intranasal corticosteroid indicated for the management of chronic rhinosinusitis (CRS) without nasal polyps and for nasal allergy in adults and adolescents ≥12 y. Mechanism of Action Budesonide nanoparticle formulation: The aerosolized drug penetrates the nasal mucosa and is retained on the mucosal surface for up to 24 h. Intracellular: Budesonide binds to … Read more
Vortioxetine Vortioxetine (brand name Luvoxix in some markets, generic vortioxetine) is a multimodal serotonin‑modulating antidepressant approved for major depressive disorder (MDD). Mechanism of Action Primary action: Selective serotonin reuptake inhibitor (SSRI) with high affinity for the serotonin transporter (SERT). Secondary actions: Agonist at 5‑HT₁A receptors (enhances serotonergic neurotransmission). Partial agonist at 5‑HT₁B receptors. Antagonist at … Read more
Voriconazole Voriconazole is a second‑generation triazole antifungal used for invasive fungal infections, particularly those caused by Aspergillus spp. and resistant Candida spp. It achieves high intralesional concentrations and is available orally and intravenously, making it ideal for step‑down therapy. Mechanism of Action Inhibits CYP14A (sterol‑14α‑demethylase) – a fungal cytochrome P450 enzyme that converts lanosterol to … Read more